Cargando…

Frontal inverted papillomas: A 25‐year study

OBJECTIVES/HYPOTHESIS: This study analyzes the treatment outcomes of frontal inverted papillomas (FIPs) in an attempt to provide guidelines for surgery selection. STUDY DESIGN: Retrospective case series. METHODS: The treatment results of 29 FIPs classified into five categories were retrospectively a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sham, Cheuk Lun, van Hasselt, C. Andrew, Chow, Samuel M. W., Lee, Dennis L. Y., Cho, Ryan H. W., Woo, John K. S., Tong, Michael C. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318241/
https://www.ncbi.nlm.nih.gov/pubmed/31418865
http://dx.doi.org/10.1002/lary.28245
_version_ 1783550801940054016
author Sham, Cheuk Lun
van Hasselt, C. Andrew
Chow, Samuel M. W.
Lee, Dennis L. Y.
Cho, Ryan H. W.
Woo, John K. S.
Tong, Michael C. F.
author_facet Sham, Cheuk Lun
van Hasselt, C. Andrew
Chow, Samuel M. W.
Lee, Dennis L. Y.
Cho, Ryan H. W.
Woo, John K. S.
Tong, Michael C. F.
author_sort Sham, Cheuk Lun
collection PubMed
description OBJECTIVES/HYPOTHESIS: This study analyzes the treatment outcomes of frontal inverted papillomas (FIPs) in an attempt to provide guidelines for surgery selection. STUDY DESIGN: Retrospective case series. METHODS: The treatment results of 29 FIPs classified into five categories were retrospectively analyzed. The five categories are F1, tumor prolapsed into frontal sinus, tumor origin outside frontal sinus; F2, tumor origin inside frontal sinus, medial to the plane of lamina papyracea; F3, tumor origin inside frontal sinus, lateral to the plane of lamina papyracea; F4, bilateral; and F5, extrasinonasal. RESULTS: Of the 11 F1 cases, 73% had Draf I and 27% had Draf IIA procedures. There was one (9%) frontal recurrence and one (9%) frontal stenosis. Of the 10 F2 cases, 10% had Draf I, 40% had Draf IIA, 40% had Draf IIB, and 10% had Draf III surgery with a trephination. One patient (10%) had a frontal recurrence. Of the five F3 cases, 40% had Draf IIA surgery, 20% had external frontoethmoidectomy, and 40% had external frontal sinusotomy. The recurrence rate was 60%, and frontal stenosis rate was 60%. The two F4 cases had external frontal sinusotomies and Draf III surgery with no frontal recurrence or stenosis. The patient with the F5 had a frontal recurrence after Draf IIA surgery and external frontoethmoidectomy. CONCLUSIONS: Draf I or IIA surgery is adequate for most F1 tumors, and Draf II surgery is adequate for most F2 tumors. F3 and F4 tumors can be managed initially by Draf III surgery with external frontal sinusotomy added when required. F5 tumors probably require combined surgical approaches. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:1622–1628, 2020
format Online
Article
Text
id pubmed-7318241
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73182412020-06-29 Frontal inverted papillomas: A 25‐year study Sham, Cheuk Lun van Hasselt, C. Andrew Chow, Samuel M. W. Lee, Dennis L. Y. Cho, Ryan H. W. Woo, John K. S. Tong, Michael C. F. Laryngoscope Allergy, Rhinology, and Immunology OBJECTIVES/HYPOTHESIS: This study analyzes the treatment outcomes of frontal inverted papillomas (FIPs) in an attempt to provide guidelines for surgery selection. STUDY DESIGN: Retrospective case series. METHODS: The treatment results of 29 FIPs classified into five categories were retrospectively analyzed. The five categories are F1, tumor prolapsed into frontal sinus, tumor origin outside frontal sinus; F2, tumor origin inside frontal sinus, medial to the plane of lamina papyracea; F3, tumor origin inside frontal sinus, lateral to the plane of lamina papyracea; F4, bilateral; and F5, extrasinonasal. RESULTS: Of the 11 F1 cases, 73% had Draf I and 27% had Draf IIA procedures. There was one (9%) frontal recurrence and one (9%) frontal stenosis. Of the 10 F2 cases, 10% had Draf I, 40% had Draf IIA, 40% had Draf IIB, and 10% had Draf III surgery with a trephination. One patient (10%) had a frontal recurrence. Of the five F3 cases, 40% had Draf IIA surgery, 20% had external frontoethmoidectomy, and 40% had external frontal sinusotomy. The recurrence rate was 60%, and frontal stenosis rate was 60%. The two F4 cases had external frontal sinusotomies and Draf III surgery with no frontal recurrence or stenosis. The patient with the F5 had a frontal recurrence after Draf IIA surgery and external frontoethmoidectomy. CONCLUSIONS: Draf I or IIA surgery is adequate for most F1 tumors, and Draf II surgery is adequate for most F2 tumors. F3 and F4 tumors can be managed initially by Draf III surgery with external frontal sinusotomy added when required. F5 tumors probably require combined surgical approaches. LEVEL OF EVIDENCE: 4 Laryngoscope, 130:1622–1628, 2020 John Wiley & Sons, Inc. 2019-08-16 2020-07 /pmc/articles/PMC7318241/ /pubmed/31418865 http://dx.doi.org/10.1002/lary.28245 Text en © 2019 The Authors. The Laryngoscope published by Wiley Periodicals, Inc. on behalf of The American Laryngological, Rhinological and Otological Society, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Allergy, Rhinology, and Immunology
Sham, Cheuk Lun
van Hasselt, C. Andrew
Chow, Samuel M. W.
Lee, Dennis L. Y.
Cho, Ryan H. W.
Woo, John K. S.
Tong, Michael C. F.
Frontal inverted papillomas: A 25‐year study
title Frontal inverted papillomas: A 25‐year study
title_full Frontal inverted papillomas: A 25‐year study
title_fullStr Frontal inverted papillomas: A 25‐year study
title_full_unstemmed Frontal inverted papillomas: A 25‐year study
title_short Frontal inverted papillomas: A 25‐year study
title_sort frontal inverted papillomas: a 25‐year study
topic Allergy, Rhinology, and Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318241/
https://www.ncbi.nlm.nih.gov/pubmed/31418865
http://dx.doi.org/10.1002/lary.28245
work_keys_str_mv AT shamcheuklun frontalinvertedpapillomasa25yearstudy
AT vanhasseltcandrew frontalinvertedpapillomasa25yearstudy
AT chowsamuelmw frontalinvertedpapillomasa25yearstudy
AT leedennisly frontalinvertedpapillomasa25yearstudy
AT choryanhw frontalinvertedpapillomasa25yearstudy
AT woojohnks frontalinvertedpapillomasa25yearstudy
AT tongmichaelcf frontalinvertedpapillomasa25yearstudy